Helix

About

Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.

San Mateo,California,United States
101 - 250
http://www.helix.com

Highlights

Details

Last Funding Type: Grant
Last Funding Money Raised: $33M
Industries: Big Data,Bioinformatics,Biotechnology,Genetics,Health Care,Personal Health
Founded date: Jul 15, 2015
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Helix OpCo LLC

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$403M

Helix has raised a total of $403M in funding over 2 rounds. Their latest funding was raised on Jun 3, 2021 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 3, 2021	Series C	$50M	5	Warburg Pincus	—	Detail
Jul 31, 2020	Grant	$33M	1	National Institutes of Health	—	Detail
Mar 1, 2018	Series B	$200M	7	DFJ Growth	—	Detail
Oct 27, 2017	Series Unknown	$20M	2	Kleiner Perkins	—	Detail
Aug 15, 2015	Series A	$100M	5	Illumina	—	Detail

Investments

Number of Investments

Number of Lead Investments

1

Helix has made 1 investments. Their most recent investment was on Aug 29, 2022, when Anuva raised 0.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 29, 2022 Anuva	Series A	—	Health Care	Yes

Investors

Number of Lead Investors

Number of Investors

5

11

Helix is funded by 11 investors. Warburg Pincus and National Institutes of Health are the most recent investors.

Investor Name	Lead Investor	Funding Round
Warburg Pincus	Yes	Series C
National Institutes of Health	Yes	Grant
DFJ Growth	—	Series C
Kleiner Perkins	—	Series C
Mayo Clinic Ventures	—	Series C
Temasek Holdings	—	Series C
Illumina	—	Series B
Mayo Clinic	—	Series B
Sutter Hill Ventures	—	Series B
Casdin Capital	—	Series Unknown